Publications by authors named "Renee Simms"

Claim this Profile
P
Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study).
Wei Jiang, Selmir Avdic, Koon H Lee, Janine Street, Gloria Castellano-González, Renee Simms

Leukemia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.
David J Gottlieb, Gaurav Sutrave, Wei Jiang, Selmir Avdic, Janine A Street, Renee Simms

Am J Hematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.
Wei Jiang, Leighton E Clancy, Selmir Avdic, Gaurav Sutrave, Janine Street, Renee Simms

Blood Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.
David C Bishop, Leighton E Clancy, Renee Simms, Jane Burgess, Geetha Mathew

Blood· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program.
Barbara Withers, Leighton Clancy, Jane Burgess, Renee Simms, Rebecca Brown

Biol Blood Marrow Transplant· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Peptide Pulsed Dendritic Cell Vaccination in Addition to T Cell Adoptive Immunotherapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
Chun K K Ma, Leighton Clancy, Renee Simms, Jane Burgess, Shivashni Deo

Biol Blood Marrow Transplant· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells.
Barbara Withers, Emily Blyth, Leighton E Clancy, Agnes Yong, Chris Fraser, Renee Simms

Blood Adv· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation.
Chun K K Ma, Emily Blyth, Leighton Clancy, Renee Simms, Jane Burgess

Cytotherapy· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
Leighton E Clancy, Emily Blyth, Renee M Simms, Kenneth P Micklethwaite, Chun-Kei K Ma

Biol Blood Marrow Transplant· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation.
Emily Blyth, Leighton Clancy, Renee Simms, Chun K K Ma, Jane Burgess

Blood· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients.
Emily Blyth, Shivashni S Gaundar, Leighton Clancy, Renee M Simms, Ian Bilmon

Cytotherapy· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro generation of influenza-specific polyfunctional CD4+ T cells suitable for adoptive immunotherapy.
Shivashni S Gaundar, Emily Blyth, Leighton Clancy, Renee M Simms, Chun K K Ma

Cytotherapy· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses.
Emily Blyth, Leighton Clancy, Renee Simms, Shivashni Gaundar, Philip O'Connell

Transplantation· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis